EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent

医学 前列腺癌 放射治疗 医学物理学 癌症 放射科 内科学
作者
Philip Cornford,Roderick C.N. van den Bergh,Erik Briers,Thomas Van den Broeck,Oliver Brunckhorst,Julie Darraugh,Daniel Eberli,Gert De Meerleer,Maria De Santis,Andrea Farolfi,Giorgio Gandaglia,Silke Gillessen,Nikolaos Grivas,Ann Henry,Michael Lardas,Geert J.L.H. van Leenders,Matthew Liew,Estefanía Linares,Jan Oldenburg,Inge M. van Oort,Daniela E. Oprea‐Lager,Guillaume Ploussard,Matthew J. Roberts,Olivier Rouvière,Ivo G. Schoots,Natasha Schouten,Emma Jane Smith,Johan Stranne,Thomas Wiegel,Peter-Paul Willemse,Derya Tilki
出处
期刊:European Urology [Elsevier]
卷期号:86 (2): 148-163 被引量:88
标识
DOI:10.1016/j.eururo.2024.03.027
摘要

The European Association of Urology (EAU)-European Association of Nuclear Medicine (EANM)-European Society for Radiotherapy and Oncology (ESTRO)-European Society of Urogenital Radiology (ESUR)-International Society of Urological Pathology (ISUP)-International Society of Geriatric Oncology (SIOG) guidelines provide recommendations for the management of clinically localised prostate cancer (PCa). This paper aims to present a summary of the 2024 version of the EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on the screening, diagnosis, and treatment of clinically localised PCa. The panel performed a literature review of all new data published in English, covering the time frame between May 2020 and 2023. The guidelines were updated, and a strength rating for each recommendation was added based on a systematic review of the evidence. A risk-adapted strategy for identifying men who may develop PCa is advised, generally commencing at 50 yr of age and based on individualised life expectancy. The use of multiparametric magnetic resonance imaging in order to avoid unnecessary biopsies is recommended. When a biopsy is considered, a combination of targeted and regional biopsies should be performed. Prostate-specific membrane antigen positron emission tomography imaging is the most sensitive technique for identifying metastatic spread. Active surveillance is the appropriate management for men with low-risk PCa, as well as for selected favourable intermediate-risk patients with International Society of Urological Pathology grade group 2 lesions. Local therapies are addressed, as well as the management of persistent prostate-specific antigen after surgery. A recommendation to consider hypofractionation in intermediate-risk patients is provided. Patients with cN1 PCa should be offered a local treatment combined with long-term intensified hormonal treatment. The evidence in the field of diagnosis, staging, and treatment of localised PCa is evolving rapidly. These PCa guidelines reflect the multidisciplinary nature of PCa management. This article is the summary of the guidelines for "curable" prostate cancer. Prostate cancer is "found" through a multistep risk-based screening process. The objective is to find as many men as possible with a curable cancer. Prostate cancer is curable if it resides in the prostate; it is then classified into low-, intermediary-, and high-risk localised and locally advanced prostate cancer. These risk classes are the basis of the treatments. Low-risk prostate cancer is treated with "active surveillance", a treatment with excellent prognosis. For low-intermediary-risk active surveillance should also be discussed as an option. In other cases, active treatments, surgery, or radiation treatment should be discussed along with the potential side effects to allow shared decision-making.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
revew666发布了新的文献求助30
1秒前
1秒前
迷路的映雁完成签到 ,获得积分10
2秒前
3秒前
3秒前
3秒前
思源应助唯一采纳,获得10
3秒前
乘风的法袍完成签到,获得积分10
5秒前
超文献发布了新的文献求助10
5秒前
6秒前
杏林靴子发布了新的文献求助10
6秒前
正直尔白完成签到 ,获得积分10
6秒前
李承恩发布了新的文献求助10
6秒前
空白完成签到,获得积分10
8秒前
炒蛋汉堡完成签到,获得积分10
8秒前
万能图书馆应助guantlv采纳,获得10
9秒前
大个应助Hcw0525采纳,获得10
9秒前
科研顺完成签到 ,获得积分10
10秒前
阿喵完成签到,获得积分10
10秒前
11秒前
机智谷蕊完成签到,获得积分10
11秒前
11秒前
慕青应助超文献采纳,获得10
11秒前
yoyo完成签到 ,获得积分10
12秒前
ML完成签到,获得积分10
12秒前
nater1ver完成签到,获得积分10
12秒前
遇楹完成签到 ,获得积分10
13秒前
14秒前
海洋完成签到,获得积分10
14秒前
哭泣老三完成签到 ,获得积分10
15秒前
Gleaming完成签到,获得积分10
15秒前
cimy完成签到,获得积分10
15秒前
qingqing168完成签到,获得积分10
16秒前
16秒前
再寄一丘青完成签到,获得积分10
17秒前
细腻静枫完成签到 ,获得积分10
17秒前
KWang发布了新的文献求助10
18秒前
天天快乐应助huazhangchina采纳,获得10
19秒前
YL完成签到,获得积分20
19秒前
nater2ver完成签到,获得积分10
19秒前
高分求助中
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Bayesian Models of Cognition:Reverse Engineering the Mind 888
Handbook of Qualitative Cross-Cultural Research Methods 600
Very-high-order BVD Schemes Using β-variable THINC Method 568
Chen Hansheng: China’s Last Romantic Revolutionary 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3137214
求助须知:如何正确求助?哪些是违规求助? 2788251
关于积分的说明 7785413
捐赠科研通 2444284
什么是DOI,文献DOI怎么找? 1299869
科研通“疑难数据库(出版商)”最低求助积分说明 625639
版权声明 601023